Elotuzumab, CC-92480, and Dexamethasone for the Treatment of Relapsed or Refractory Myeloma After CD38- and BCMA-Targeted Therapies

NCT05981209 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Multiple Myeloma
Refractory Multiple Myeloma

Interventions

PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Aspiration
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
DRUG: Dexamethasone
PROCEDURE: Echocardiography
BIOLOGICAL: Elotuzumab
PROCEDURE: Magnetic Resonance Imaging
BIOLOGICAL: Mezigdomide
PROCEDURE: X-Ray Imaging

Sponsor

Abdullah Khan